Skip to main content

Advertisement

Table 2 Baseline characteristics of glycemic metabolism

From: Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome

Variables All patients Low MAGE High MAGE p-Value
(n = 417) (n = 268) (n = 149)
75 g OGTT findings
 Diabetes mellitus, n (%) 140 (34) 55 (21) 85 (57) < 0.001 
 Impaired glucose tolerance, n (%) 185 (44) 135 (50) 50 (34) < 0.001
 Normal glucose tolerance, n (%) 92 (22) 78 (29) 14 (9) < 0.001
 Glucose on admission, mg/dl 142 (118–182) 133 (114–165) 163 (130–217) < 0.001
 Glucose on admission > 180 mg/dl 105 (25) 49 (18) 56 (38) < 0.001
 Hemoglobin A1c level, % 5.9 (5.5–6.4) 5.8 (5.5–6.1) 6.3 (5.7–7.3) < 0.001
CGM findings
 MAGE, mg/dl 40.6 (27.59.5) 31.8 (24.39.7) 65.0 (57.8–79) < 0.001
 Ave, mg/dl 120 (108–136) 115 (106–126) 134 (120–170) < 0.001
 SD 17.0 (12.1–25.1) 13.5 (10.5–17.2) 28 (22.4–35.9) < 0.001
 CV 14.0 (10.2–18.7) 11.3 (9.1–14.2) 19.7 (16.4–23.6) < 0.001
  1. OGTT oral glucose tolerance test, CGM continuous glucose monitoring, MAGE mean amplitude of glycemic excursions, Ave average, SD standard deviation, CV coefficient of variation